Tags

Type your tag names separated by a space and hit enter

A meta-analysis of extracorporeal shock wave therapy for Peyronie's disease.
Int J Impot Res. 2016 Sep; 28(5):161-6.IJ

Abstract

The efficiency of extracorporeal shock wave therapy (ESWT) for Peyronie's disease (PD) has been controversial for a very long time. We aimed to evaluate the efficiency of ESWT for PD and provide possible evidence on the basis of a meta-analysis of existing comparative studies. All controlled studies, including randomized controlled trials (RCTs), cohort studies and case-control studies, that focused on the efficiency of ESWT for PD, were prospectively identified through comprehensive searches of PubMed, the Cochrane Library and Embase databases. We conducted a meta-analysis of these studies. Six studies including 443 patients were selected for the meta-analysis. Pooling data of these studies showed that ESWT could significantly increase the percentage of men with lessening of penile plaques (odds ratio (OR) 2.07, 95% confidence interval (CI) 1.11-3.85, P=0.02), relief of pain (OR 4.46, 95% CI 2.29-8.68, P<0.0001) and complete remission of pain (OR 5.86, 95% CI 2.66-12.92, P<0.0001). However, insignificant differences were found in improvement of penile curvature (OR 1.88, 95% CI 0.97-3.65, P=0.06) and sexual function (OR 2.22, 95% CI 0.69-7.11, P=0.18) between ESWT and placebo groups. Further, similar results were shown for sensitivity and publication bias analysis when only RCTs were included. However, sporadic complications caused by ESWT were reported, but no patient needed additional treatment aside from conservative observation. ESWT may be an effective and safe treatment for lessening of penile plaques and relieving pain for men with PD, but not for improving of penile curvature and sexual function.

Authors+Show Affiliations

The Andrology Laboratory and Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, China.The Andrology Laboratory and Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, China.The Andrology Laboratory and Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, China.The Andrology Laboratory and Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, China.The Andrology Laboratory and Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, China.

Pub Type(s)

Journal Article
Meta-Analysis
Review

Language

eng

PubMed ID

27250868

Citation

Gao, L, et al. "A Meta-analysis of Extracorporeal Shock Wave Therapy for Peyronie's Disease." International Journal of Impotence Research, vol. 28, no. 5, 2016, pp. 161-6.
Gao L, Qian S, Tang Z, et al. A meta-analysis of extracorporeal shock wave therapy for Peyronie's disease. Int J Impot Res. 2016;28(5):161-6.
Gao, L., Qian, S., Tang, Z., Li, J., & Yuan, J. (2016). A meta-analysis of extracorporeal shock wave therapy for Peyronie's disease. International Journal of Impotence Research, 28(5), 161-6. https://doi.org/10.1038/ijir.2016.24
Gao L, et al. A Meta-analysis of Extracorporeal Shock Wave Therapy for Peyronie's Disease. Int J Impot Res. 2016;28(5):161-6. PubMed PMID: 27250868.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - A meta-analysis of extracorporeal shock wave therapy for Peyronie's disease. AU - Gao,L, AU - Qian,S, AU - Tang,Z, AU - Li,J, AU - Yuan,J, Y1 - 2016/06/02/ PY - 2015/11/06/received PY - 2016/02/01/revised PY - 2016/04/12/accepted PY - 2016/6/3/entrez PY - 2016/6/3/pubmed PY - 2017/5/5/medline SP - 161 EP - 6 JF - International journal of impotence research JO - Int J Impot Res VL - 28 IS - 5 N2 - The efficiency of extracorporeal shock wave therapy (ESWT) for Peyronie's disease (PD) has been controversial for a very long time. We aimed to evaluate the efficiency of ESWT for PD and provide possible evidence on the basis of a meta-analysis of existing comparative studies. All controlled studies, including randomized controlled trials (RCTs), cohort studies and case-control studies, that focused on the efficiency of ESWT for PD, were prospectively identified through comprehensive searches of PubMed, the Cochrane Library and Embase databases. We conducted a meta-analysis of these studies. Six studies including 443 patients were selected for the meta-analysis. Pooling data of these studies showed that ESWT could significantly increase the percentage of men with lessening of penile plaques (odds ratio (OR) 2.07, 95% confidence interval (CI) 1.11-3.85, P=0.02), relief of pain (OR 4.46, 95% CI 2.29-8.68, P<0.0001) and complete remission of pain (OR 5.86, 95% CI 2.66-12.92, P<0.0001). However, insignificant differences were found in improvement of penile curvature (OR 1.88, 95% CI 0.97-3.65, P=0.06) and sexual function (OR 2.22, 95% CI 0.69-7.11, P=0.18) between ESWT and placebo groups. Further, similar results were shown for sensitivity and publication bias analysis when only RCTs were included. However, sporadic complications caused by ESWT were reported, but no patient needed additional treatment aside from conservative observation. ESWT may be an effective and safe treatment for lessening of penile plaques and relieving pain for men with PD, but not for improving of penile curvature and sexual function. SN - 1476-5489 UR - https://wwww.unboundmedicine.com/medline/citation/27250868/A_meta_analysis_of_extracorporeal_shock_wave_therapy_for_Peyronie's_disease_ DB - PRIME DP - Unbound Medicine ER -